Australia's new HPV‐based cervical screening program is based on an algorithm that
incorporates reflex cytology to guide decisions about further follow‐up with colposcopy and …

Objectives To report human papillomavirus (HPV) testing patterns and rates of oncogenic
HPV‐positivity for specimens submitted during the first 6 months after the National Cervical …

OBJECTIVE: To characterize the cervical cancers diagnosed following a Pap-negative, high
risk human papillomavirus (HPV)-positive (Pap−/HPV+) screen in routine clinical practice …

Objective The use of testing for human papillomavirus (HPV) is now recognized as an
efficient means of triaging women with low‐grade cytological abnormalities to either …

Human papillomavirus (HPV) testing is more sensitive than cytology; some cervical cancer
prevention programs will switch from cytology to carcinogenic HPV test‐based screening …

Objective. The goal of this study was to investigate whether expanded cytologic referral
criteria for colposcopy or the addition of human papillomavirus (HPV) testing on cervical …

J. Bowring, R. Albrow, A. Fisher, G. Downey, J. Cullimore, J. Patnick, PG Walker and HC
Kitchener A prospective study of human papillomavirus (HPV) testing to resolve uncertainty …

To evaluate the risk of false HPV‐negative results and possible related morphological
abnormalities in HPV primary cervical cancer screening. Out of 53,661 HPV‐negative cases …

This study compares colposcopy referrals of 2 management strategies: oncogenic human
papillomavirus (HPV)–DNA testing (Hybrid Capture 2 assay, Qiagen, Germantown, MD) and …

Background: Human papillomavirus (HPV) testing is more sensitive than cytology for
detecting high-grade cervical intraepithelial neoplasia (CIN). We evaluated the performance …